Data Science Funding Announcements & Notices
Data science and informatics funding announcements and notices are available from NCI and NIH programs. Browse below for opportunities, requests for information, notices, and initiatives.
| Title | FOA | Organization | Release Date | Expire Date Sort descending | Purpose |
|---|---|---|---|---|---|
| Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed) | PAR-22-090 | NCI | The purpose of this engineering-oriented funding opportunity announcement (FOA) is to encourage submissions of exploratory/developmental Bioengineering Research Grant (EBRG) applications to… More | ||
| Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional) | PAR-22-091 | NCI | The purpose of this engineering-oriented funding opportunity announcement (FOA) is to encourage submissions of exploratory/developmental Bioengineering Research Grant (EBRG) applications to… More | ||
| Bioengineering Partnerships with Industry (U01 Clinical Trial Optional) | PAR-22-123 | NIBIB | This Funding Opportunity Announcement (FOA) solicits applications from research partnerships formed by academic and industrial investigators to accelerate the development and adoption of promising… More | ||
| NIAID Career Transition Award (K22 Independent Clinical Trial Not Allowed) | PAR-22-075 | NIAID | The purpose of the NIAID Career Transition Award (CTA) program is to assist postdoctoral fellows' transition to positions of assistant professor or equivalent and initiate a successful… More | ||
| Drug Discovery For Nervous System Disorders (R01 Clinical Trials Not Allowed) | PAR-22-031 | NIMH | Reissue of PAR-19-147 This Funding Opportunity Announcement (FOA) supports the discovery of novel compounds for the prevention and treatment of nervous system disorders. Through this FOA NIMH… More |
||
| Drug Discovery For Nervous System Disorders (R21 Clinical Trials Not Allowed) | PAR-22-032 | NIMH | Reissue of PAR-19-146 This Funding Opportunity Announcement (FOA) supports the discovery of novel compounds for the prevention and treatment of nervous system disorders. Through this FOA NIMH… More |
||
| Basic Neurodevelopmental Biology of Circuits and Behavior (R21 Clinical Trial Not Allowed) | PAR-22-067 | NIMH | Reissue of PAR-19-028 This Funding Opportunity Announcement (FOA) solicits research projects focused on the dynamic and mechanistic links between the maturation of brain circuits and behaviors across… More | ||
| Basic Neurodevelopmental Biology of Circuits and Behavior (R01 Clinical Trial Not Allowed) | PAR-22-066 | NIMH | Reissue of PAR-19-027 This Funding Opportunity Announcement (FOA) solicits research projects focused on the dynamic and mechanistic links between the maturation of brain circuits and behaviors across… More | ||
| Modulating Human Microbiome Function to Enhance Immune Responses Against Cancer (R21 Clinical Trial Not Allowed) | PAR-22-062 | NCI | The purpose of this Funding Opportunity Announcement (FOA) is to support exploratory/development basic research projects that elucidate mechanisms by which the human microbiome inhibit or enhance… More | ||
| Modulating Human Microbiome Function to Enhance Immune Responses Against Cancer (R01 Clinical Trial Not Allowed) | PAR-22-061 | NCI | The purpose of this Funding Opportunity Announcement (FOA) is to support basic research that elucidates mechanisms by which the human microbiome inhibit or enhance anti-tumor immune responses, and to… More |